Veru, Inc. (VERU)
2.61
-0.04
(-1.51%)
USD |
NASDAQ |
Dec 09, 14:16
Veru Cash from Investing (Quarterly): 0.4741M for June 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Onconetix, Inc. | 0.00 |
| CEL-SCI Corp. | 0.00 |
| AIM ImmunoTech, Inc. | 0.296M |
| IGC Pharma, Inc. | -0.374M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.482M |
| Free Cash Flow | -28.98M |
| Free Cash Flow Per Share (Quarterly) | -0.374 |
| Free Cash Flow to Equity (Quarterly) | -5.348M |
| Free Cash Flow to Firm (Quarterly) | -5.482M |
| Free Cash Flow Yield | -9.79% |